Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis

Psychological Medicine

Volumn 39, Issue 6, 2009, Pages 951-956

  Mason, O ^a   Morgan, C J A ^a   Dhiman, S K ^a   Patel, A ^a,a   Parti, N ^a   Curran, H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acute; Cannabis; Psychosis; Schizotypy; Vulnerability

Indexed keywords

CANNABIS; PSYCHOTROPIC AGENT; PSYCHEDELIC AGENT;

ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS SMOKING; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG USE; FEMALE; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PARALLEL DESIGN; PERSONAL EXPERIENCE; PERSONALITY TEST; PSYCHOSIS; QUESTIONNAIRE; RISK FACTOR; SCHIZOTYPAL PERSONALITY DISORDER; SCORING SYSTEM; SYMPTOM; ADOLESCENT; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; HALLUCINATION; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; UNITED KINGDOM;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CANNABIS; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HALLUCINATIONS; HALLUCINOGENS; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 69249235551     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291708004741     Document Type: Article

References (20)

1. Barkus E, Lewis S (2008). Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychological Medicine. Published online : 21 January 2008. doi:10.1017/S0033291707002619.
2. Barkus E, Stirling J, Hopkins R, Lewis S (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 139-178. (Pubitemid 43909769)
3. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieve R, Krystal JH (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals : implications for research. Neuropsychopharmacology 29, 1558-1572.
4. D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J (2008). Blunted psychotomimetic and amestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology. Published online : 9 January 2008. doi:10.1038/sj.npp. 1301643.
5. Di Forti M, Morrison PD, Butt A, Murray RM (2007). Cannabis use and psychiatric and cognitive disorders : the chicken or the egg? Current Opinion in Psychiatry 20, 228-234.
6. Favrat B, Ménétrey A, Augsburger M, Rothuizen LE, Appenseller M, Buclin T, Pin M, Mangin P, Giroud C (2005). Two cases of 'cannabis acute psychosis' following the administration of oral cannabis. BMC Psychiatry 5, 17-19.
7. Fergusson DM, Horwood LJ, Ridder EM (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354-366. (Pubitemid 40363442)
8. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11-15. (Pubitemid 40070467)
9. Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB (2007) Cannabis and schizophreia : model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia. Addiction 102, 597-606.
10. Mason OJ, Morgan CJA, Stefanovic A, Curran HV (2008). The Psychotomimetic States Inventory (PSI) : measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 103, 138-142.
11. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis L (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319-328. (Pubitemid 47094993)
12. Morgan CJA, Curran HV (2008). Effects of cannabidiol on schizophrenia-like symptoms in cannabis users. British Journal of Psychiatry 192, 306-307.
13. Morgan CJA, Rossell S, Pepper F, Smart J, Blackburn J, Brandner B, Curran HV (2006). Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 59, 265-272. (Pubitemid 43208974)
14. Raine A (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555-564.
15. Skosnik PD, Spatz-Glenn L, Park S (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 83-92. (Pubitemid 32241185)
16. 11C]raclopride PET study. Neuropsychopharmacology. Published online : 24 October 2007. doi:10.1038/sj.npp.1301597.
17. UNODC (2007). World Drug Report. United Nations Office on Drugs and Crime, 2007. Vienna, Austria.
18. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD (2003). Effects of cannabis and psychosis vulnerability in daily life : an experience sampling test study. Psychological Medicine 33, 23-32. (Pubitemid 36113397)
19. Williams JH, Wellman NA, Rawlins JNP (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869-878.
20. Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia : interactions with tobacco and cannabis use. British Journal of Psychiatry 191, 402-407. (Pubitemid 350069580)